The global orthopedic device markett is witnessing transformative growth, fueled by technological advancements, an aging population, and rising demand for minimally invasive treatments. Innovations such as regenerative therapies, AI-assisted surgical systems, and next-generation implants are redefining patient care standards worldwide.
The Canadian landscape is evolving rapidly, driven by innovation, regulatory excellence, and patient-focused initiatives.
🏥 The Canadian Orthopedic Association continues to play a pivotal role in maintaining the highest standards of orthopedic care for patients nationwide. By supporting education, research, and advocacy, the association ensures Canadian patients receive world-class treatment.
Download Sample: https://www.towardshealthcare.com/download-sample/5721
📑 Meanwhile, the Canadian government remains committed to ensuring the safety, effectiveness, and quality of medical devices. Health Canada’s rigorous approval process fosters trust and sets a global benchmark for medical innovation.
🌟 A recent milestone highlights this progress:
In February 2025, Contura Orthopedics announced the launch of Contura Orthopedics (Canada) Ltd. The move aims to supply Arthrosamid, a Health Canada-approved treatment for knee pain caused by osteoarthritis, offering new hope to thousands of Canadians living with joint discomfort
Download Databook : https://www.towardshealthcare.com/download-databook/5721
✨ Why It Matters
🦵 Osteoarthritis affects 1 in 6 Canadians over the age of 45.
💡 The arrival of Arthrosamid provides a novel, non-surgical option for managing knee pain.
🌐 This development underscores Canada’s position as a leader in adopting safe and effective orthopedic innovations.
📌 Takeaway
With strong professional associations, proactive government regulations, and industry breakthroughs, Canada’s orthopedic market is well-poised for growth in 2025 and beyond. Patients and providers alike can look forward to more accessible, advanced, and effective orthopedic care solutions.
Request a customized case study tailored to your business needs and gain deeper insights into healthcare market strategies: sales@towardshealthcare.com
The global clear aligners market is expected to grow from USD 6.51 billion in 2024 to USD 99.44 billion by… Read More
The global skincare market is a rapidly expanding industry, valued at USD 115.69 billion in 2024, projected to grow to… Read More
The global pharmaceutical excipients market was valued at USD 10.41 billion in 2024, grew to USD 10.83 billion in 2025,… Read More
The global cannabidiol market was USD 8.97 billion in 2024, grew to USD 10.38 billion in 2025, and is projected… Read More
The global bioreactors market was valued at USD 15.06 billion in 2024, is forecast at USD 16.74 billion in 2025,… Read More
The global smart healthcare market was valued at USD 283.41 billion in 2024 and is expected to reach USD 335.85… Read More